Skip to main content
ILLUMINA, INC. logo

ILLUMINA, INC. — Investor Relations & Filings

Ticker · ILMN ISIN · US4523271090 LEI · SQ95QG8SR5Q56LSNF682 US Manufacturing
Open in API
Filings indexed 2,572 across all filing types
Latest filing 2021-04-16 Proxy Solicitation & In…
Country US United States of America
Listing US ILMN

About ILLUMINA, INC.

https://www.illumina.com

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company is a provider of DNA sequencing and array-based technologies. Its portfolio includes next-generation sequencing (NGS) platforms, microarrays, library preparation kits, and bioinformatics software. These products and services are utilized by researchers and clinicians for applications in life science research, translational and consumer genomics, molecular diagnostics, oncology, and reproductive health. The company's solutions are designed to advance genomic discoveries and enable precision medicine by providing tools for DNA, RNA, and protein analysis.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a definitive proxy statement or additional materials related to a shareholder meeting. It includes information about voting on director elections, auditor ratification, and executive compensation advisory votes. The text explicitly mentions it is a 'Definitive Additional Materials' filing related to the proxy statement for the Annual Meeting. It is not the proxy statement itself but additional materials related to it. The document is short (4212 characters) and primarily serves to inform shareholders about voting and proxy materials availability. This fits the category of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2021-04-16 English
DEF 14A
Proxy Solicitation & Information Statement
2021-04-16 English
PRIMARY DOCUMENT
Director's Dealing
2021-04-07 English
PRIMARY DOCUMENT
Director's Dealing
2021-04-07 English
PRIMARY DOCUMENT
Director's Dealing
2021-04-07 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 5, 2021, by Illumina, Inc. It announces preliminary revenue for the first quarter ended April 4, 2021, and updates revenue guidance for the fiscal year ending January 2, 2022. The document includes a press release as Exhibit 99.1. The text explicitly states that the information is a press release and is not filed as part of a formal financial report. The document length is 3535 characters, which is relatively short and consistent with an earnings release announcement rather than a full report. The content corresponds to an initial announcement of quarterly financial results, which fits the definition of an Earnings Release (ER).
2021-04-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.